|1.||Gupta, Aditya K: 3 articles (03/2008 - 07/2003)|
|2.||Nguyen, Kytai T: 2 articles (05/2013 - 12/2012)|
|3.||Wadajkar, Aniket S: 2 articles (05/2013 - 12/2012)|
|4.||Cooper, Elizabeth A: 2 articles (03/2008 - 07/2003)|
|5.||Ryder, Jennifer E: 2 articles (03/2008 - 05/2005)|
|6.||Boor, P J: 2 articles (12/2006 - 09/2001)|
|7.||Trent, M B: 2 articles (12/2006 - 09/2001)|
|8.||Conklin, D J: 2 articles (12/2006 - 09/2001)|
|9.||Newbury, Sandra: 1 article (12/2013)|
|10.||Coyner, Kimberly: 1 article (12/2013)|
02/01/2005 - "All mice which received 5 mg kg(-1) daily for 9 consecutive days, or 200 mg kg(-1) in a single dose of the bromo derivative of 2-propen-1-amine, survived after an infection with 10(4) trypomastigotes/ml of the Y-strain of T. "
01/01/2004 - "Yeast infections such as those caused by Candida albicans respond less well to allylamine drugs. "
11/25/1991 - "A new allylamine derivative for local and peroral use in fungal infections]."
10/01/1990 - "This in vitro profile is reflected by the clinical effectiveness of this allylamine in the treatment of dermatophyte infections. "
09/01/1994 - "Terbinafine is an allylamine and has been found to be effective and safe in brief therapy of dermatophyte infections. "
01/01/2002 - "All these results suggest that the combined deactivators-supplemented medium is more useful for mycological evaluation of therapeutic efficacy of imidazole and allylamine drugs against dermatophytoses in both preclinical and clinical studies."
02/01/1997 - "In studies using animal models of dermatophytosis, results have shown the efficacy of the allylamine/benzylamine drugs to be superior to that of azole drugs. "
04/01/2008 - "Terbinafine is an allylamine antifungal agent, effective in the treatment of dermatomycoses. "
03/01/2008 - "Naftifine is a topical allylamine that is effective and safe in the management of superficial dermatomycoses. "
12/01/1984 - "A new subclass, which features an acetylene group conjugated with the allylamine double bond, is characterized by enhanced antifungal activity, especially on oral treatment of guinea pig dermatophytoses. "
|3.||Onychomycosis (Tinea Unguium)
02/01/1992 - "Terbinafine is an allylamine antifungal compound shown to be effective in the oral treatment of onychomycosis. "
05/01/2005 - "Terbinafine is an allylamine with fungicidal activity, first approved for the treatment of onychomycosis in the United Kingdom in the early 1990s, and in the US in 1996. "
02/01/2002 - "Terbinafine, an allylamine used to treat onychomycosis, has been reported to be active against rat Pneumocystis carinii in vitro and in vivo. "
05/01/1998 - "Terbinafine is an allylamine antifungal agent used for the treatment of onychomycosis. "
05/01/2003 - "Terbinafine is an allylamine fungicidal agent that is widely used for the treatment of onychomycoses and other fungal infections. "
01/01/1990 - "As the intrinsic susceptibility to atherosclerosis differs among several taxonomic groups, the present studies were conducted to compare the angiotoxic responses of atherosclerosis-susceptible (quail) and -resistant (rat) animals to allylamine, a selective cardiovascular toxin. "
07/15/1999 - "Allylamine (AA) is a cardiovascular toxin that causes lesions resembling atherosclerosis in several mammalian species. "
02/01/1998 - "Allylamine (AA, 3-aminopropene) is a specific cardiovascular toxin used experimentally to model myocardial necrosis and atherosclerosis. "
05/01/1987 - "Allylamine has been given by a variety of routes to many species in attempts to cause lesions which mimic human acute vasculitis, acute myocardial necrosis, and atherosclerosis; examples of typical lesions are illustrated. "
10/01/1998 - "The purpose of this study was to compare the efficacy of GT16-239, an alkylated, cross-linked poly(allylamine) bile acid sequestrant with cholestyramine on cholesterol and bile acid metabolism, and early aortic atherosclerosis in hypercholesterolemic male F1B Golden Syrian hamsters. "
03/01/2006 - "After clinical diagnosis and microscopic confirmation, tinea cruris is best treated with a topical allylamine or an azole antifungal (strength of recommendation: A, based on multiple randomized controlled trials [RCTs]). "
05/15/2002 - "Tinea corporis and cruris infections are usually treated for two weeks, while tinea pedis is treated for four weeks with an azole or for one to two weeks with allylamine medication. "
04/01/1994 - "This study compared the efficacy of the new fungicidal allylamine antimycotic, terbinafine, with the triazole antimycotic, itraconazole, in patients with chronic tinea imbricata. "
03/01/2006 - "The fungicidal allylamines (naftifine and terbinafine) and butenafine (allylamine derivative) are a more costly group of topical tinea treatments, yet they are more convenient as they allow for a shorter duration of treatment compared with fungistatic azoles (clotrimazole, econazole, ketoconazole, oxiconazole, miconazole, and sulconazole)."
|3.||naftifine (naftifine hydrochloride)
|6.||Potassium Iodide (Pima)
|7.||Cholestyramine Resin (Questran)
|2.||Drug Therapy (Chemotherapy)
|4.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)